Location but not severity of endoscopic lesions at baseline influences endoscopic healing rates in Crohn's disease patients treated with infliximab: a post-hoc analysis of the TAILORIX trial

Pauline Riviere  1     Geert R. D'Haens  2     Laurent Peyrin-Biroulet  3     Filip Baert  4     Guy Lambrecht  5     Benjamin Pariente  6     Peter Bossuyt  7     Anthony Buisson  8     Bas Oldenburg     Severine Vermeire     David Laharie    
1 Bordeaux University Hospital,Pessac,France
2 AMC Amsterdam Inflammatory Bowel Disease Centre,Amsterdam,Netherlands
3 Nancy University Hospital, Lorraine University,Nancy,France
4 Az Delta,Roeselare,Belgium
5 AZ Damiaan,Oostende,Belgium
6 Lille University,Lille,France
7 Imelda Ziekenhuis,Bonheiden,Belgium
8 CHU Estaing Clermont-Ferrand,Cler

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing